Pharmaceutical Industry Case Study

Great Essays
Chapter-1
Introduction to Indian Pharmaceutical Industry

1.1 Introduction

The Indian pharmaceutical industry holding the top most position among all science based technology spread with wide ranging of technicalities in the complex field of drug manufacturing and drug innovations. The Indian pharmaceutical industry stands fourth in terms of volume and attained the fourteen in terms of value. Export of Indian pharmaceutical industry works as a fuel for the growth of the industry. The Indian pharmaceutical industry is exporting in almost all developed countries and facing the severe competition and government price control regulations.
In the last two decades, Indian pharmaceutical industry has expanded significantly. It has more than 250
…show more content…
Gastrointestinal category further divided into few categories that are Anticholinergics, Antidiarrheals Antiemetics, Antiulcer Medications. This category got the success to have the 11 per cent in the classification.
1.8.3 Antibiotics:

Antibiotics are used to treat an ample variety of bacterial infections. Antibiotics inhibit the growth of bacteria by interfering with the production of certain biochemical, which is compulsory for sustaining the bacteria’s life. This course of action supports the body in defending from bacterias and take very less time in eliminating the infection. This category has the largest share among the rest ones.
1.8.4 Analgesics:
The analgesic category also called as ‘Pain Killer’ category. All members of this category are used to achieve analgesia- relief from the pain. The word is a Greek word which means without pain. Analgesic drugs act in various ways on the peripheral or central nervous systems. Analgesics include paracetamol, the non-steroid, anti-inflammatory drugs. Analgesic category attains the fourth position in the same classification. This category is one of the common
…show more content…
With the modernizing of Indian Pharmaceutical Industry, it creates several benefits to the same. These are as follows.
1.11.1.2 Social:
As the Indian drug industry is developing, it creates new job opportunities. Indian drug industry is providing new drug formulations and efficient health care system to its patients. For the new discoveries companies are investing a huge amount in R&D, and patients are able to have the medicines & treatment of critical diseases.
1.11.1.3 Economic:
The development of pharmaceutical industry would help the Indian economy and producing more national wealth. Indian companies have the opportunity to merge with foreign companies which indirectly promotes the foreign investment in India. Growth of Indian pharmaceutical industry generates the job opportunities in India, and if a citizen gets the domestic job opportunity they would not feel the pressure of migrating United States. Expansion of Indian pharmaceutical industry is promoting the vast growth of Indian economy.
1.11.1.4

Related Documents

  • Great Essays

    The Medicines Company Case

    • 1116 Words
    • 5 Pages

    The Medicines Company is a newly formed firm that has interesting business model. Medicines Company acquires drugs that have been abandoned from other pharmaceutical companies due to lack of early state research results. Medicines Company’s success relies on their ability to save “rejected” compounds, receive FDA approval for their used, and to make a profit of the drug. This case study mainly focuses at the first years of this new startup company, mainly on the initial review of their first “saved” drug called Angiomax. Angiomax is a former abandon anticoagulant drug of Biogen. Biogen drop the researches of this drug due to them not believing the benefits did not outweigh the costs.…

    • 1116 Words
    • 5 Pages
    Great Essays
  • Improved Essays

    Morphine and Codeine, are the most powerful pain treatments. These usually are reserved for the most intense pain.…

    • 676 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Drug companies will have large increases of new prescription drugs being developed that have promising potential in combating diseases. Also medical device companies will benefit, the technology has advanced from a $3 billion dollar cost to sequence the human genome in 1990 to new equipment capable to repeat the process faster and for less than $3 thousand dollars. This will lead to creating drug therapies that are designed specifically for each patient. Technology advancements in Healthcare IT may revolutionize Electronic Medical Records (EMR) and the capability to have your medical history on your smartphone in the form of an app. (Waggoner, 2012)…

    • 1084 Words
    • 5 Pages
    Improved Essays
  • Brilliant Essays

    Taking this case into consideration there are alternatives to importation. According to joseph Bast a more effective way to lower the cost of drugs would be to streamline the approval process for new and generic drugs and limit lawsuit abuse, which would contribute to lowering the cost of drugs. When taking into consideration the potential problems when importing prescription drugs, a safer way to go would be to reduce the amount of regulations on the testing of new drugs, many of the regulations are unimportant and the many companies only follow them for a fear of facing a lawsuit. If the unnecessary regulations were taken out, there would be less time to produce new drugs. Many companies also stay away from making new prescriptions because of all of the regulations that they are forced to adhere to, many that may not apply to the current drug that they are testing. This in turn makes the price of drugs go up, because when there are less new drugs being created there are only the companies that produced the drugs to begin…

    • 1170 Words
    • 5 Pages
    Brilliant Essays
  • Superior Essays

    Purinex Case Study

    • 1463 Words
    • 6 Pages

    The pharmaceutical industry was known one of the most effective economic sector and have more than 530$ billion in sales. The company grew faster than most other divisions of the economic, but they forecasted the…

    • 1463 Words
    • 6 Pages
    Superior Essays
  • Improved Essays

    Over Medicated Essay

    • 512 Words
    • 3 Pages

    Last year, pharmacist filled 4,468,929,929 prescriptions in the United States that is an 85 percent increase from just twenty years earlier (Carr, Rabkin, and Skinner 38). With these kinds of numbers, it must be obvious the process to develop drugs in America is working like a well-oiled machine, or is it? Prescription drug companies, the Food and Drug Administration (FDA) and independent research companies including universities all work together to develop improved medications. Each one has an unbiased, independent role to play in the process, however, over the years the unbiased independent part has become blurred. The Federal Government has made changes to regulations and health care policies, consequently, the prescription drug company’s…

    • 512 Words
    • 3 Pages
    Improved Essays
  • Decent Essays

    Medication is mainly concerned with providing capitalist with healthy workforce. There should be a focus on medical treatment rather than to prevent the ill-health, big companies are supported and with the interest…

    • 208 Words
    • 1 Pages
    Decent Essays
  • Great Essays

    Cost Of Healthcare

    • 1442 Words
    • 6 Pages

    The pharmaceutical industry has lost the trust of the American people and it is doubtful that they will be able to win it back any time soon. Americans are frustrated, and rightly so, at the greed associated with medicine. “The pharmaceutical industry likes to depict itself as a research-based industry, as the source of innovative drugs. Nothing could be further from the truth. This is their incredible PR and their nerve.”…

    • 1442 Words
    • 6 Pages
    Great Essays
  • Great Essays

    Epipen Case Study

    • 1781 Words
    • 8 Pages

    In turn, pharmaceutical prices have also increased, as seen with the price of the EpiPen. Furthermore, a study done by the Congressional Budget Office emphasizes the lack of the output of new drugs in recent years, which highlights the need for an increase in further research and development (“Research and Development,” 2006). This being said, society’s need for new, innovative pharmaceuticals is only possible through further research and development, which requires sufficient funding from pharmaceutical companies that is attained through drug…

    • 1781 Words
    • 8 Pages
    Great Essays
  • Superior Essays

    Clinical trials have been performed at many sites around the world for many years to obtain approvals in multiple countries. The harmonization of regulatory processes developed by the ICH, drug patent laws, and country specific regulations is very important steps towards the product development, such as drug discovery, early development and preclinical testing, clinical trials and marketing authorizations. Nearly every country agrees to accept the ICH technical necessities for registration of pharmaceutical products for human use. Taking this into an account makes very easy to perform worldwide clinical trials by outsourcing and offshoring models to achieve the numerous regulatory and commercial incentives obtainable in many countries. The perfect time to build a regulatory strategy is before submitting an Investigational New Drug (IND) application. Pre-IND meeting also requires submitting a development plan with the meeting documents. The format of the strategy documents depends on the company, its culture, and the past experience of regulatory submission needs to be included in the final document. A strategy document is an organized combination of all the sides of the drug development from pre-IND to the NDA and up to product commercialization approved by several stakeholders. The document is an excel spreadsheet or a working “book,” it must capture and documented any changes to the…

    • 1496 Words
    • 6 Pages
    Superior Essays
  • Improved Essays

    The core of the pharmaceutical industry problems consists of the expiration of patents, rising R&D expenses, and uncertainties facing new researched products and their abnormal methods of circulation of returns from said product.…

    • 703 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    The American economy greatest market for the pharmaceutical industry in 2004 the tax cuts and the lower interest rates stimulated expansion…

    • 1499 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    Takeda Pharmaceutical Company following a strategy to achieve these vision and plans, by focusing on the values, people, R&D, and Business performance, to achieve the vision of 2025.They are aiming in the long term to to become an industry leader, offering a lot of opportunity to their employs to thrive , developed and grow based on merit, potential and ambition regardless of gender , age , disability , nationality, race ,sexual orientation and gender identity , religion, experience, belief , value , or lifestyle .…

    • 788 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    As Pfizer and Johnson & Johnson were among the top ten companies, the total revenue generated in 2016 is equivalent to 5.2 percent of the market value. Firstly, as Pfizer, Inc, the world’s second largest pharmaceutical company, the New York City-based company only had generated approximately 53 billion US dollars of the total revenue. This reflects the vulnerability of Pfizer towards the local economy because the major production of well-known drugs were carried out within US such as Lipitor, Lyrica, Enbrel and Viagra. In addition, with an extensive level of research and development within and outside of US, Pfizer is exposed to global economy where 60 percent of its total revenue, almost 26.4 billion dollars were generated from abroad. To illustrate, Pfizer has over 500 subsidiaries including research and developments departments and manufacturing companies and also with the total 98,000 employees in operations throughout the world. Due to Pfizer operates internationally, Pfizer faces foreign exchange risk, geographic risk, and also legal risk. The exposure of foreign risk was due to over 60 percent of Pfizer’s total revenue is from non-U.S. markets. Pfizer able to reduce its geographic risk by operating globally, so any changes of economic condition of one market would not affect others and also Pfizer is vulnerable to legal risks such as patent rights and trademarks. With having drug manufacturing as their core business, the company faces many legal issues related to…

    • 826 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    In this step, most of the economic forces come into play; namely pricing and competition. In terms of pricing, does the company price its drugs above its production costs or does it research the price that the market would bear? (Hooper, 2008). The answer is never that easy. Companies that wish to maximise profit will set high prices for consumers that are willing to pay; however, the same drug in a poor country might be priced lower (Hooper, 2008). The drug Crixivan, for example, is priced differently in Africa than it is in the US. Merck, the company that manufactures Crixivan is able to charge over six thousand dollars for a year’s supply in the US; however, the same drug costs six hundred dollars in Africa for a year’s supply (Hooper, 2008). The other economic force is competition. Although brand-name drug manufacturers do compete between each other based on price, another form of competition, which will be discussed later, is the rise of the generics industry. The rise of the generics industry can be contributed to government policy whereby governments allow generic-drug makers to conduct research on patented drugs prior to the expiry of the patent. This presents consumers with a lower cost equivalent of the brand name drug. The ascent of generic-drug manufacturers, could be argued, is attributed to the public interest theory of…

    • 984 Words
    • 4 Pages
    Improved Essays